Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High rates of early treatment discontinuation in hepatitis C-infected US veterans.

BMC research notes - 24 Apr 2014

LaFleur Joanne, Hoop Robert, Morgan Timothy, DuVall Scott L, Pandya Prashant, Korner Eli, Knippenberg Kristin, Hayden Candace, Nelson Richard E

Abstract excerpt

BACKGROUND: Patients with chronic hepatitis C (HCV) frequently discontinued dual therapy with pegylated interferon alfa (Peg-IFN) plus ribavirin (RBV) before reaching the recommended duration of 48 or 24 weeks for genotypes (G) 1/4 or 2/3, respectively. We quantified rates of discontinuation despite efficacy (non-LOE) versus lack of efficacy (LOE) versus discontinuation for unknown reasons in a national database...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genotype
Share to Hepatitis C, Chronic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Natural Language Processing

Share to Time Factors

Share to Treatment Outcome

Share to United States

Share to Veterans

Source

Open in PubMed Open full text

Identifiers

PMID: 24758162
DOI: 10.1186/1756-0500-7-266
PMCID: PMC4012175

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High rates of early treatment discontinuation in hepatitis C-infected US veterans.PMID 24758162Read ↗

Predictors of early treatment discontinuation among patients with genotype 1 hepatitis C and implications for viral eradication.Semantic proximity Read ↗

Sustained Virological Response After Early Discontinuation of Hepatitis C Treatment.Semantic proximity Read ↗

An open-safety study of dual antiviral therapy in real-world patients with chronic hepatitis C.Semantic proximity Read ↗

Disease Burden, Early Discontinuation, and Healthcare Costs in Hepatitis C Patients with and without Chronic Kidney Disease Treated with Interferon-Free Direct-Acting Antiviral Regimens.Semantic proximity Read ↗

Early discontinuation of ribavirin in HCV-2 and HCV-3 patients responding to Peg-interferon alpha-2a and ribavirin.Semantic proximity Read ↗

Predictive variables of sustained virological response after early discontinuation of triple therapy with telaprevir for genotype-1 HCV infection.Semantic proximity Read ↗

Standard Versus Extended Duration Direct-Acting Antiviral Therapy in Hepatitis C Patients With Slow Response to Treatment.Semantic proximity Read ↗

Loss to follow-up of patients after antiviral treatment as an additional barrier to HCV eliminationSemantic proximity Read ↗

Factors associated with treatment interruption for Hepatitis C.Semantic proximity Read ↗

Effectiveness of telaprevir and boceprevir triple therapy for patients with hepatitis C virus infection in a large integrated care setting.Semantic proximity Read ↗

Meta-analysis shows extended therapy improves response of patients with chronic hepatitis C virus genotype 1 infection.Semantic proximity Read ↗

Barriers to treatment of failed or interferon ineligible patients in the era of DAA: single center study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.